Literature DB >> 10544083

Development of a novel mouse model for dengue virus infection.

J An1, J Kimura-Kuroda, Y Hirabayashi, K Yasui.   

Abstract

In the present study, we established an animal model for dengue virus infection using severe combined immunodeficient mice transplanted with a human hepatocarcinoma cell line (HepG2). At 7-8 weeks after transplantation, the HepG2-grafted mice were infected intraperitoneally with dengue virus type 2 (DEN-2). A higher titer of the virus was detected in the liver and serum but not in the brain in the early stage of postinfection. When the mice showed paralysis, the highest titer of virus was detected in the serum and brain. DEN-2 antigens were also found in HepG2 cells of the liver in the early stage and some neurons of the brain in the late stage. Upon clinical examination, thrombocytopenia, prolonged partial thromboplastin time, and increased hematocrit, blood urea nitrogen, and tumor necrosis factor alpha were seen in the paralyzed mice. Moreover, mild hemorrhage in the liver and tarry stool in the small intestine were observed in some mice. Our results show some similarities to human DEN infection and this mouse model might be valuable for studying some aspects of pathogenesis of this disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10544083     DOI: 10.1006/viro.1999.9887

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  The pathogenesis of spinal cord involvement in dengue virus infection.

Authors:  Jing An; De-Shan Zhou; Kazunori Kawasaki; Kotaro Yasui
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

2.  Mouse STAT2 restricts early dengue virus replication.

Authors:  Joseph Ashour; Juliet Morrison; Maudry Laurent-Rolle; Alan Belicha-Villanueva; Courtney Ray Plumlee; Dabeiba Bernal-Rubio; Katherine L Williams; Eva Harris; Ana Fernandez-Sesma; Christian Schindler; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  Potential of ancestral sylvatic dengue-2 viruses to re-emerge.

Authors:  Nikos Vasilakis; Elisabeth J Shell; Eric B Fokam; Peter W Mason; Kathryn A Hanley; D Mark Estes; Scott C Weaver
Journal:  Virology       Date:  2006-10-02       Impact factor: 3.616

4.  Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.

Authors:  J E Blaney; D H Johnson; C Y Firestone; C T Hanson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  In vivo infection by a neuroinvasive neurovirulent dengue virus.

Authors:  Myriam Lucia Velandia-Romero; Orlando Acosta-Losada; Jaime E Castellanos
Journal:  J Neurovirol       Date:  2012-07-24       Impact factor: 2.643

6.  The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity.

Authors:  Sophie Alcon-LePoder; Marie-Thérèse Drouet; Pascal Roux; Marie-Pascale Frenkiel; Michel Arborio; Anne-Marie Durand-Schneider; Michèle Maurice; Isabelle Le Blanc; Jean Gruenberg; Marie Flamand
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

9.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.

Authors:  Smita Jaiswal; Todd Pearson; Heather Friberg; Leonard D Shultz; Dale L Greiner; Alan L Rothman; Anuja Mathew
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.